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Putative epithelial stem cells in the hair follicle bulge
are thought to play pivotal roles in the homeostasis,
aging, and carcinogenesis of the cutaneous epithelium.
Elucidating the role of bulge cells in these processes
has been hampered by the lack of gene promoters that
target this area with speci¢city. Here we describe the
isolation of the mouse keratin 15 (K15) promoter and
demonstrate its utility for preferentially targeting hair
follicle bulge cells in adult K15/lacZ transgenic mice.
We found that patterns of K15 expression and promoter
activity changed with age and correlated with levels of
di¡erentiation within the cutaneous epithelium; less
di¡erentiated keratinocytes in the epidermis of the neo-
natal mouse and in the bulge area of the adult mouse
preferentially expressed K15.These ¢ndings demonstrate
the utility of the K15 promoter for targeting epithelial
stem cells in the hair follicle bulge and set the stage
for elucidating the role of bulge cells in skin biology.
Key words: transgenic/wound healing/alopecia/aging/carcino-
genesis. J Invest Dermatol 121:963 ^968, 2003
E
pithelial stem cells in adult self-renewing tissues, such
as the epidermis and hair follicle, are thought to
maintain normal tissue homeostasis and to serve as a
reservoir for tissue replacement after wounding or hy-
perproliferative stimulation (Cotsarelis et al, 1989, 1990;
Wilson et al, 1994; Lehrer et al, 1998; Slack, 2000). As undi¡eren-
tiated stem cells divide, they generate daughter cells that retain
the stem cell phenotype and daughter cells (called transient- or
transit-amplifying (TA) cells) that undergo a ¢nite number of
cell divisions before terminally di¡erentiating (Watt and Hogan,
2000; Cairns, 2002; Potten and Booth, 2002). Epithelial stem cells
persist for long periods and therefore can be detected as label-
retaining cells (LRC; Bickenbach and Mackenzie, 1984; Cotsarelis
et al, 1990; Morris and Potten, 1999). Although they rarely prolif-
erate, they have a high proliferative potential and proliferate at
times of tissue expansion such as during development, during
wound healing, and at the onset of a new hair growth cycle (ana-
gen; Lavker and Sun, 1982; Bickenbach and Mackenzie, 1984;
Morris et al, 1986; Cotsarelis et al, 1989; Wilson et al, 1994; Lyle
et al, 1998). Much evidence suggests that cutaneous tumors arise
from epithelial stem cells (reviewed in Morris, 2000), thus the abil-
ity to target these cells is important for studying carcinogenesis.
We ¢rst localized putative epithelial stem cells as LRC to the
hair follicle bulge of both mouse and human skin (Cotsarelis et al,
1990; Lyle et al, 1998). The bulge area of the hair follicle consists of
a cluster of cells located at the lowermost portion of the ‘‘perma-
nent’’ follicle (Cotsarelis et al, 1990; Lyle et al, 1998, 1999). Cells be-
low this area degenerate during the catagen stage of the hair
follicle cycle and regenerate at the onset of anagen (Cotsarelis
et al, 1990; Cotsarelis and Millar, 2001). Bulge cells are strategi-
cally located to repopulate both the underlying follicle and the
overlying epidermis (Fig 1F), and the ability of bulge cell pro-
geny to di¡erentiate into both of these cell populations has been
implied (Taylor et al, 2000; Oshima et al, 2001). Keratinocyte
bulge cells, like stem cells in other epithelia such as the cornea
(Schermer et al, 1986; Cotsarelis et al, 1989), possess other character-
istics of epithelial stem cells: ultrastructurally they appear less-dif-
ferentiated, and biochemically they possess a unique cytokeratin
pro¢le (Cotsarelis et al, 1990; Lyle et al, 1998). Recent evidence
demonstrating that melanocyte precursors also localize to the
bulge supports the notion that this area forms a niche for the
maintenance of the stem cell phenotype (Nishimura et al, 2002).
Because cytokeratins generally are expressed in a di¡erentia-
tion-speci¢c manner (Fuchs and Cleveland, 1998), keratin (K)
promoter regions have proven invaluable for targeting transgene
expression to speci¢c compartments within epithelia. For exam-
ple, the K5 and K14 promoters drive expression of transgenes to
the relatively undi¡erentiated basal cell layer of the epidermis and
hair follicle, whereas the K10 promoter targets the more di¡eren-
tiated suprabasal cells of these tissues (Vassar et al, 1989; Bailleul
et al, 1990; Byrne and Fuchs, 1993; Ramirez et al, 1994). The use of
these promoters in transgenic mice has resulted in major advances
in understanding of epidermal and hair follicle development,
proliferation, di¡erentiation, and carcinogenesis (Oro et al, 1997;
Brown et al, 1998; Gat et al, 1998; Grachtchouk et al, 2000;Waikel
et al, 2001; Santos et al, 2002). Nonetheless, none of the existing
promoters target epithelial stem cells with speci¢city. This major
limitation impedes determining the contribution of stem cells to
the phenotype of transgenic mice.
We previously demonstrated that hair follicle bulge cells in
human scalp speci¢cally express K15 (Lyle et al, 1998, 1999), and
here we describe that K15 is preferentially expressed in adult
mouse bulge cells as well.We hypothesized that the K15 promoter
would target hair follicle bulge cells. Therefore, we cloned the
up-stream region of the K15 gene and generated K15/lacZ trans-
genic reporter mice. We demonstrated that the K15 promoter
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speci¢cally targets hair follicle bulge cells in adult transgenic mice
and that the targeted cells are predominantly LRC. Thus, K15
expression correlates with a less di¡erentiated and quiescent
keratinocyte phenotype, and the K15 promoter serves as a valuable
tool for targeting hair follicle bulge cells.
MATERIALS AND METHODS
In situ hybridization PCR-derived riboprobe templates were
synthesized by introducing the T7 promoter into sense and antisense
templates as described (Sitzmann and LeMotte, 1993) with some
modi¢cation. One primer pair, mK15F (50 -GCAGTAGCAGCAGC
AGCAATTTC-30) and mK15R-T7 (50 -GTAATACGACTCACTATAG
GGCCACTCAGAAGGAAGCCGAGAAAGC-30), was used to generate
the DNA template for the antisense riboprobe spanning 263BP of the 30
end of the mouse K15 cDNA. Similarly, a primer pair consisting of
mK15F-T7 (50 -GTAATACGACTCACTATAGGGCGCAGTAGCAGCAG
CAGCAATTTC-30) and mK15R (50 -CACTCAGAAGGAAGCCGA
GAAAGC-30) was used to amplify template for sense riboprobe. PCR
procedures were carried out at 941C for 30 s, 551C for 1 min, and 721C
for 1 min, for 30 cycles. The PCR products were separated on an agarose
gel and puri¢ed with the QIAquick extraction kit (Qiagen, Chatsworth,
CA). These templates were used to synthesize antisense and sense
digoxigenin-labeled riboprobes with a DIG RNA labeling kit (Roche,
Indianapolis, IN) according to the manufacturer’s instructions.
In situ hybridization was performed using the digoxigenin-labeled
riboprobes essentially as described previously (Hebert et al, 1994). Four
percent paraformaldehyde-¢xed and para⁄n-embedded BALB/c mouse
skin tissue sections were depara⁄nized with xylene, rehydrated, treated
with 20 mg per mL proteinase keratin, and post¢xed with 4%
paraformaldehyde for 10 min. The sections were then hybridized to
digoxigenin-labeled antisense and sense K15 RNA probes (500 ng/mL) at
551C overnight. The slides were washed at high stringency with 0.2X SSC
at 681C for 45 min, treated with anti-digoxigenin antibody (Roche)
coupled to horseradish peroxidase, and ampli¢ed with the tyramide signal
ampli¢cation kit (NEN Life Science, Boston, MA). The slides were then
developed in diaminobenzidine/H2O2 substrate (Sigma Chemical Co., St.
Louis, MO) and counterstained with hematoxylin Gill’s Formulation No. 3
(Fisher Scienti¢c, Hampton, NH).
Generation of K15-speci¢c antisera A peptide corresponding to the
carboxy-terminal 12 amino acids of human K15, CDGQVVSSHKREI
(Lloyd et al, 1995), was synthesized and coupled through its N-terminal
cysteine residue to keyhole limpet hemocyanin via MBS (Pierce 22310).
The conjugated peptide was used to immunize chickens with standard
protocols at Cocalico Biologicals, Inc. (Reamstown, PA). Brie£y, for the
initial inoculation, 100 mg of conjugated peptide was emulsi¢ed in
complete Freund’s adjuvant and injected into the breast muscle of chickens
whose sera samples had been prescreened by immunohistochemistry to be
certain that it contained no endogenous keratin antibodies. Three weeks
later, 50 mg of conjugated peptide emulsi¢ed in incomplete Freund’s adju-
vant was injected to boost antibody production. After 10 d, the antibody
titer of the ¢rst test serum sample was analyzed by immuno-
histochemistry. The chickens were further boosted with 50 mg of
conjugate peptide and sera samples were collected 10 d after each boost.
The sera samples were puri¢ed with an a⁄nity column made from the
peptide and cyanogen bromide-activated Sepharose 4B (Pharmacia) and
then used for immunostaining and immunoblotting.
Immunoblotting Cell lysates from primary cultured human foreskin
keratinocytes and ¢broblasts were run on 10% SDS^PAGE and blotted
onto polyvinylidene di£uoride membranes. Blots were blocked in 5%
nonfat dried milk in phosphate-bu¡ered saline (PBS), 0.2% Tween 20 for
1 h at room temperature and then incubated with a⁄nity-puri¢ed chicken
Figure1. K15 gene and protein expres-
sion in mouse skin. (A^C) In situ hybridi-
zation with K15-speci¢c riboprobe showed
expression of K15 in basal cells of neonatal
epidermis and in bulge cells in mature skin.
The dashed line denotes the dermal/epidermal
junction. Arrows point to the bulge. (D) Im-
munoblot using chicken anti-K15 antibody
demonstrating detection of B48-kDa band
in protein from human keratinocytes (KC)
and not ¢broblasts (F). (E) Immunostaining
of PAM212 cells (mouse keratinocyte cell
line) with anti-K15 antibody demonstrated
cytoplasmic staining in a ¢lamentous pat-
tern characteristic of intermediate ¢laments
(K15, green; nuclear Hoechst stain, blue). (F)
Diagram depicting hair follicles in anagen
and telogen. K5 and K14 promoters are ac-
tive throughout the epidermal and hair folli-
cle basal layers (red), including bulge (green).
(G^L) Immunostaining of mouse skin at
di¡erent ages. Note positive staining for
K15 in hair follicle bulge (arrows) and lack
of staining for K15 in adult epidermis. Con-
trols (G,H) performed with secondary (anti-
chicken) antibody alone. Arrowheads denote
sebaceous gland, which stains nonspeci¢-
cally (bars, 25 mm).
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anti-K15 antibody (1:500) or preimmune serum for 2 h at room tem-
perature, followed by horseradish peroxidase-conjugated anti-chicken immuno-
globulins (1:2000, Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) for
1 h. After being washed, blots were developed with diaminobenzidine (Sigma
Chemical Co.).
Anti-K15 Immunohistochemistry Immunostaining was performed
similarly to previous descriptions (Lyle et al, 1998). Mouse skin was ¢xed
in Bouin’s ¢xative at room temperature overnight. Samples were then
cleared with multiple 70% rinses and stored in 70% ethanol for 1 to
3 d before para⁄n embedding and tissue sectioning. PAM212 cells
were grown on glass coverslips and ¢xed with acetone. Endogenous
peroxidases were quenched using 0.6% H2O2 in methanol. Samples were
blocked for 20 min in 1X PBS, 0.1% Triton X-100, 0.1% bovine serum
albumin (Sigma Chemical Co.), and 5% normal goat serum (Sigma
Chemical Co.). Sections were incubated overnight at 41C with chicken
anti-K15 antibody (1:200). After being rinsed, samples were then
incubated for 1 h in 1:200 biotinylated goat anti-chicken IgG (Kirkegaard
& Perry Laboratories, Inc.) and then incubated in 1:500 strepta-
vidin:horseradish peroxidase conjugate (Gibco BRL/Life Technologies,
Inc., Gaithersburg, MD). Slides were washed and incubated for 7 min in
Sigma Fast 3,30 -diaminobenzidine tablet sets diaminobenzidine substrate
solution (Sigma Chemical Co.). The reaction was stopped using distilled
water, and then samples were counterstained using a 1:10 dilution of
hematoxylin Gill’s Formulation No. 3 (Fisher Scienti¢c), dehydrated
through xylene, and coverslipped using Permount solution.
Cloning of K15 promoter The K15 (-5.0) promoter was cloned from
C57 BL/SJ mouse genomic DNA (isolated from tail) by PCR using the
Supermix High Fidelity Kit (GIBCO). The sequences of the forward and
reverse primers were. CTGAGCTACCAGCGAGACTCC (K15F1) and
TTCCTGTCCCTAGCAAGCAGGAGAG (K15R1), respectively. XhoI
and EcoRI restriction sequences were added to the 50 end of forward and
reverse primers respectively for subsequent cloning of the PCR product
into PBK/CMV vector (Stratagene). Similarly, the K15(-1.3) partial
promoter sequence was cloned by using a forward primer K15F2
(AGCCTCAGTGCATTCCACG), 1342 bp upstream of K15 start codon
and primer K15R1. K15(-3.7) was cloned by using primer K15F1 and
primer K15R2 (GCTCTCCTTCGTGGAATGCAC) located 1315 to 1335
upstream of the K15 start codon.
Luciferase assays Mouse PAM212 cells (Roop et al, 1983) were grown to
30% to 50% con£uence in six-well plates with 1:3 Ham’s F-12 medium
(Gibco) and Dulbecco’s modi¢ed Eagle’s medium supplemented with 10%
fetal calf serum and 1% penicillin/streptomycin. Cells were cotransfected
with 1.5 nM K15/PGL3 construct and 0.4 mg of pSV-b- galactosidase
control vector (Promega, Madison, WI) using 20 mL LipofectAMINE
reagent (Gibco) according to the manufacturer’s protocol. Cell extracts
were prepared 48 h after transfection, and luciferase and b-galactosidase
activities were determined using a Dual-Light kit (PE Biosystems) on a
TD20e luminometer (Turner). b-Galactosidase activity was used to
normalize transfection e⁄ciency. Luciferase/b-galactosidase ratios of K15/
pGL3 constructs were compared to pGL3-Basic Vector (baseline control)
to determine the relative activity of various K15/PGL3 constructs. All
transfections were performed in duplicate at least three separate times
with reproducible results.
Generation of transgenic mice The lacZ reporter gene was cloned
downstream of the K15 promoter (Fig 2). Transgenic mice were produced
by the University of PennsylvaniaTransgenic and Chimeric Mouse facility.
The transgene was released by digestion with XhoI/SalI (K15/lacZ) and
microinjected into fertilized eggs from a B6SJLF1/JB6SJLF1/J cross
(Jackson Laboratories, Bar Harbor, ME). Transgenic mice were identi¢ed
by southern blotting or PCR of tail biopsy DNA using transgene-speci¢c
probes or primers. All animal protocols were approved by the University
of Pennsylvania IACUC.
Histochemical assay of b-galactosidase activity We initially evalua-
ted several b-galactosidase staining techniques, including the use of frozen
sections. We found that the formaldehyde/glutaraldehyde protocol
described here provided the best morphology with equal intensity of
signal as frozen sections. Mouse tissue samples were ¢xed in freshly
prepared 2% formaldehyde/0.2% glutaraldehyde in PBS at 41C for 1 to 2
h and then washed in three changes of PBS at room temperature for 1 h.
Fixed tissue was incubated at 221C overnight in 1 mg per mL X-Gal (5
mM K-ferrocyanide, 5 mM K-ferricyanide, 2 mM MgCl2) in PBS. Then
tissue was washed with PBS, ¢xed in formalin, and embedded in para⁄n.
Five-micrometer-thick tissue sections were counterstained with Fast Red
nuclear stain.
Generation of LRC-containing K15/lacZ transgenic mice K15/lacZ
neonatal mice were injected subcutaneously with tritiated thymidine (5
mCi per pup, twice per day, starting on postnatal day (PN) 3, for a total of
3 d ) or bromodeoxyuridine (200 mg per pup per day, starting on PN3 for a
total of 3 d), and then chased for 50 days, similar to previous descriptions to
generate mice containing LRC (Cotsarelis et al, 1990; Morris and Potten,
1994). Autoradiography and immunohistochemistry were performed as
described previously (Cotsarelis et al, 1989; Morris and Potten, 1994; Lyle
et al, 1998).
RESULTS
K15 expression marks the least di¡erentiated cells of the
neonatal epidermis and adult hair follicle bulge To
determine K15 expression patterns in mouse skin during
postnatal development and maturation, we used in situ
hybridization with K15-speci¢c riboprobes (Fig 1A^C) and
immunohistochemistry (Fig 1G^L) with a chicken polyclonal
antibody that we raised against a peptide corresponding to the
12 amino acids from the carboxy terminus of the human K15
protein (see Materials and Methods and Lloyd et al, 1995). The
speci¢city of the antibody was con¢rmed by immunoblotting
protein from human keratinocytes, which demonstrated a single
band atB48 kDa, the expected size for the K15 protein (Fig 1D).
Figure 2. Isolation and characterization of K15 promoter. (A) Geno-
mic organization of K15 promoter region. The K15 coding region lies B5
kb downstream to the K19 coding region.We cloned three presumptive K15
promoter regions, indicated by the double-headed arrows. Restriction enzyme
sites and consensus sequences for selected transcription factor binding sites
are indicated. (B) Results of in vitro luciferase assays demonstrated that the
full-length (5.0-kb) promoter has the highest activity. PGL3b refers to the
luciferase construct lacking a promoter. (C) K15/lacZ construct. The 5.0-kb
promoter region was used to generate transgenic mice. SD/SA, splice donor/
splice acceptor.
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This antibody also stained a subset of PAM212 cells, a mouse
keratinocyte cell line, in a pattern characteristic of intermediate
¢lament proteins (Fig 1E).
Strong expression of K15 mRNA and protein was uniform-
ly concentrated in the hair follicle bulge of older mice
(Fig 1B,C,K,L), similar to the human scalp (Lyle et al, 1999).
Epidermal expression of K15, at both the mRNA and the
protein levels, was present in younger mice, but markedly
decreased in mice older than approximately 2 wk of age (Fig 1).
The preferential expression of K15 protein in the bulge cells was
present in all four types of hair follicles found in the back skin of
mice (Fig 3 and data not shown). In approximately one-third
of adult mice, variable weak expression of K15 in epidermal
keratinocytes was detected by immunohistochemistry. Never-
theless, in all cases, K15 expression was markedly weaker in the
epidermis compared with the bulge keratinocytes, which were
uniformly positive. No di¡erence in the distribution patterns of
K15 protein was noted based on whether we used frozen or
para⁄n sections for staining with the antibody. In general,
Bouin’s-¢xed tissue generated the strongest signal for this
antibody.
Isolation of K15 promoter We cloned the entire upstream
region of the mouse K15 gene, which comprises approximately
5.0 kb between the K19 and K15 genes (Nozaki et al, 1994;
Fig 2A). To evaluate the presumptive K15 promoter regions, we
generated three di¡erent K15/luciferase constructs utilizing the
5.0, 1.3, and 5.0/3.7-kb regions located upstream to the K15-
coding region (Fig 2A).We transfected PAM212 cells with these
constructs and examined promoter activity with luciferase assays
(Fig 2B). Both the entire (5.0 kb) region and the truncated (1.3
kb) region resulted in high expression levels in vitro (Fig 2B).
Interestingly, the 5.0/3.7-kb region was not active and resulted in
100-fold lower luciferase activity compared with baseline control
levels, suggesting that the 50 region of the promoter may possess
inhibitory cis-acting elements. This was supported by our
sequencing of the promoter region (deposited in NCBI,
accession numbers BankIt486710 and AF542050), which revealed
several potential cis-regulatory elements, such as AP-1 and Sp1
sites (Fig 2A), that are important for regulation of other keratin
genes (Byrne et al, 1994; Ramirez et al, 1994; Whitbread and
Powell, 1998; Maytin et al, 1999; Brembeck and Rustgi, 2000).
These ¢ndings suggest that regulatory elements within the 50
region of the promoter may inhibit K15 expression at some level
and could be important for speci¢city of expression.
The K15 promoter targets hair follicle bulge cells in adult
transgenic mice To determine whether the presumptive K15
promoter region functions in vivo, we generated transgenic mice
carrying the full-length (5.0 kb) K15 promoter fused to the
Escherichia coli lacZ reporter gene (K15/lacZ; Fig 2C). Four K15/
lacZ founder mice were generated. Three founder mice
expressed b-galactosidase in their tail skin (by X-Gal staining),
and one was negative. One positive founder mouse appeared
runted. The other two positive founder mice had strong
expression of b-galactosidase in skin and phenotypically
appeared completely normal.We therefore used lines from these
two founders for subsequent analyses.
Figure 3. K15 promoter speci¢cally
targets bulge keratinocytes in adult
K15/lacZ transgenic mice. Histology
of X-Gal-treated K15/lacZ skin from dif-
ferent ages and body sites. Blue stain indi-
cates transgene expression. (A) PN34,
face; (B) PN28, back; (C) example of co-
localization of K15/lacZ-positive cells
and LRC (arrows). Silver grains are red-il-
luminated. (D) PN34, back; (E) PN58,
back. Hair follicles are in anagen in
A,B,D and telogen in C,E (bars, 10 mm).
Sections are counterstained with Fast
Red.
Figure 4. K15 promoter activity dur-
ing postnatal development. Skin from
K15/lacZ transgenic mice treated with X-
Gal at indicated ages. Whole mounted
(A^D) and sectioned (E^H) skin at indi-
cated ages. Early time points (A,E,F)
show epidermal K15 promoter activity.
Later time points show speci¢c K15 pro-
moter activity in bulges and lack of pro-
moter activity elsewhere (B,C,G). X-Gal-
treated nontransgenic control skin (D,H,
bars, 10 mm).
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In mice older than approximately 2 to 3 wk of age, K15/lacZ
expression strikingly localized to the bulge cells of hair follicles
from all areas of the body, including facial, back, and tail skin
throughout all stages of the hair cycle (Fig 3). This expression
pattern persisted in older mice (450 days old), which also
displayed strong b-galactosidase activity speci¢cally in the bulge.
This pattern was observed in two separate transgenic lines.
Overall, the activity of the 5.0-kb K15 promoter appeared more
speci¢c than the expression pattern of endogenous K15 protein
that was occasionally detected in the epidermis.
Majority of K15/lacZ-positive bulge cells are LRC To
examine the association between K15 promoter activity and the
stem cell phenotype in the K15/lacZ transgenic mice, we
identi¢ed quiescent cells as LRC. LRC identify presumptive
epithelial stem cells in both rodent skin and human skin grafted
to immunode¢cient mice (Bickenbach and Mackenzie, 1984;
Cotsarelis et al, 1990; Lyle et al, 1998; Morris and Potten, 1999).
We counted the number of lacZ-positive cells that were also
LRC in six nonconsecutive tissue sections from the back skin
of ¢ve mice that had received tritiated thymidine or bromo-
deoxyuridine over a 3-d period as neonates as previously
described.We found that 92%73% of the cells expressing lacZ
were also LRC (Fig 3C).
K15 promoter activity in neonatal mouse skin To further
characterize the activity of the K15 promoter, we examined skin
from K15/lacZ transgenic mice for b-galactosidase activity during
the neonatal time period (Fig 4). Although signi¢cant transgene
activity was present in the interfollicular epidermis of the neonate
(Fig 4A,E,F) by approximately PN16, epidermal promoter
activity decreased, and epidermal expression generally was lost
(Fig 4G). Adult epidermis was devoid of K15/lacZ promoter
activity (Figs 3, 4). K15 promoter activity was evident in the
bulge during folliculogenesis at PN5 (Fig 4F) and became more
prominent in the bulge during the ¢rst telogen stage at
approximately 3 wk of age.
DISCUSSION
Previously, using the K5 or K14 promoters, investigators simulta-
neously targeted transgenes to the epidermal and hair follicle
basal layers, which are contiguous (Fig 1F). The basal layer con-
tains stem cells, transient amplifying cells, and even terminally
di¡erentiating cells. Thus, the use of these existing keratin pro-
moters precludes determining whether a phenotype results from
the targeting of stem or transient amplifying cell populations.
The use of the K15 promoter, which selectively targets the hair
follicle bulge, where stem cells are thought to reside, allows for
determining the role of bulge cells in processes such as wound
healing, aging, alopecia, and carcinogenesis. In contrast to a sheep
promoter construct described previously (Whitbread and Powell,
1998), which likely included portions of both the K15 and the K19
genes and had a much wider distribution of activity, the mouse
K15 promoter described here clearly targets hair follicle bulge
cells with speci¢city in the adult. Interestingly, promoter activity
was more speci¢c for bulge cells than protein expression. Our
¢ndings of K15 expression in the epidermis, albeit at variable
and markedly lower levels than in the bulge, are in line with pre-
vious reports of K15 protein in human epidermis (Porter et al,
2000).Whether this expression is due to persistence of K15 pro-
tein in cells that have migrated from the bulge or due to expres-
sion of K15 in pre-existing epidermal cells remains to be
determined. The presence of K15 in the epidermis also suggests
that using K15 protein expression as a sole criterion for de¢ning
an epithelial stem cell would be naive. Rather, we argue that K15
protein expression only correlates with keratinocytes that are less
di¡erentiated. K15’s precise role in keratinocyte biology has yet to
be de¢ned.
During the ¢rst 2 postnatal wk in the mouse, the epidermis
undergoes a drastic alteration in its morphology, which changes
from multiple cell layers with a thick stratum corneum in the
neonate to its more mature phenotype of only three cell layers
with a thin stratum corneum in the adult (Hanson, 1947). K15 ex-
pression in the epidermis correlated with the immature epidermal
phenotype. Interestingly, K15 promoter activity in the follicle was
limited to a small number of cells in the newly developing ana-
gen follicle until after epidermal maturation when K15 promoter
activity prominently appeared in the hair follicle bulge of the
telogen follicle. Our results suggest that the loss of K15 expres-
sion in the basal epidermis and the persistence of K14 expression
(Byrne et al, 1994), during the neonatal time period, indicate a
switch to a more mature phenotype. Similar age-related changes
in keratin expression patterns occur in the basal layer of the eso-
phageal epithelium, in which K15 expression predominates in
young mice, but is then replaced by K14, the other major type I
keratin in the esophagus (Lloyd et al, 1995).
The correlation of K15 expression and K15 promoter activity
with the least di¡erentiated cell populations in the epidermis
and hair follicle supports the notion that K15 promoter activity
is a putative epithelial stem cell marker. To further test the corre-
lation between K15 promoter activity and the epithelial stem cell
phenotype, we examined the K15/lacZ-positive cells for their
ability to retain label. A cell’s ability to retain label after a long
chase period indicates that it has a quiescent phenotype, a hall-
mark of putative epithelial stem cells (Waikel et al, 2001). It has
been shown repeatedly that the bulge contains the most quiescent
cells throughout the epidermis and hair follicle, in that these cells
retain label for many months (Cotsarelis et al, 1990; Lyle et al, 1998;
Morris and Potten, 1999; Taylor et al, 2000). We found that the
large majority of K15/lacZ-positive cells are LRC. The small per-
centage of K15/lacZ cells that are not LRC likely represent tissue
sections in which the tritiated thymidine-labeled nucleus was not
sectioned or stem cells that had divided and diluted out their
label. These results are in line with cell kinetic analysis of bulge
cells isolated from the skin using a CD34 antibody (Trempus
et al, 2003).
The isolation of a K15 promoter that targets bulge cells allows
for the development of more advanced transgenic systems for
studying the bulge. In combination with promoter/enhancer ele-
ments responsive to tetracycline or hormonal agents. for example
(Diamond et al, 2000; Arnold andWatt, 2001; Liu et al, 2001), in-
ducible systems that activate oncogenes exclusively in bulge stem
cells in adult mice can now readily be developed. These are likely
to yield insights into the role of bulge cells in carcinogenesis
through lineage analysis and by speci¢c targeting of oncogenes
to the bulge cells. Similarly, an inducible K15 promoter driving
Cre recombinase can be designed for deleting genes selectively
in bulge cells of adult mice (see Cao et al, 2001). Transgenic mice
expressing green £uorescent protein can be developed for isola-
tion and characterization of bulge cells. Such approaches should
allow for the identi¢cation of speci¢c genes involved in hair fol-
licle cycling, wound healing, and other processes.
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